Dr. Ryan K. Pham, DO

Dr. Pham practices at Prestige Dermatology in Burleson, Texas.

Dr. Pham's NPI, 1407173230, was assigned on May 4, 2010. Dr. Pham graduated from Texas College of Osteopathic Medicine in 2010. Dr. Pham holds Texas license P1128.

Dr. Pham's primary practice is Prestige Dermatology, at 621 SW Johnson Ave, Burleson, TX 76028 in Johnson County. The practice phone is (817) 766-7421.

Dr. Pham's primary practice is Prestige Dermatology in Burleson, Texas. The medical group on file is Prestige Dermatology of Burleson. Dmand AI also links Dr. Pham to 6 more group practices and clinics, 5 medical groups and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pham practices, 7 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Pham's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Pham is board certified in dermatology by the AOA Board of Dermatology. Dr. Pham is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Pham treats.

CMS data shows 12,118 Medicare services from Dr. Pham across 28 procedure codes in 2024, for 694 Medicare patients. Medicare paid $240,906 for them. Every service was in an office.

CMS counts 694 Medicare patients who saw Dr. Pham in 2024. The largest group is 65 to 74, with 365 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Pham's median patient age at 52, with 56% women.

In 2024, Dr. Pham wrote 1,155 Medicare Part D claims for 488 patients. 90% of them were for generic drugs. CMS names the drug for 1,000 of them, across 17 drugs with 11 or more claims each, at $401,495 in total drug cost. In 2023, CMS named 861 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Pham for performance year 2024, reported individually. Dr. Pham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 211 procedures of melanoma (skin cancer) excision by Dr. Pham, more than 97% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Pham, published from 2009 to 2018. Dr. Pham's most frequent co-authors are Peter J. Malouf, DO, Joseph Stephen Susa, DO and Stephen E. Weis, DO.

CMS Open Payments shows 2,017 general payments to Dr. Pham from 57 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Eli Lilly and Company paid the most, $38,112.

Dmand AI lists 1 award for Dr. Pham, most recently Chief Resident in 2014.

Dr. Pham graduated from Texas College of Osteopathic Medicine in 2010. Dr. Pham is a member of AAD, AMA and AOA.

Dr. Pham is in network with 23 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.